These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 15367278

  • 1. What is the calcineurin inhibitor of choice for pediatric renal transplantation?
    Kari JA, Trompeter RS.
    Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K.
    Drugs; 2003 Oct; 63(15):1535-48. PubMed ID: 12887261
    [Abstract] [Full Text] [Related]

  • 3. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G.
    Paediatr Drugs; 2007 Oct; 9(3):165-74. PubMed ID: 17523697
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
    Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Bjorn Brekke I, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J.
    Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
    [Abstract] [Full Text] [Related]

  • 5. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.
    Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA.
    Pediatr Transplant; 2003 Jun 15; 7(3):217-22. PubMed ID: 12756047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T, Mendez R, Yang HC, Weinstein S, Jensik S, Steinberg S, Prograf Study Group.
    Transplantation; 2003 Apr 27; 75(8):1213-20. PubMed ID: 12717205
    [Abstract] [Full Text] [Related]

  • 10. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B, Tönshoff B.
    Paediatr Drugs; 2011 Feb 01; 13(1):49-69. PubMed ID: 21162600
    [Abstract] [Full Text] [Related]

  • 11. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM, Kobashigawa J, Klintmalm G.
    Clin Transplant; 2008 Feb 01; 22(1):1-15. PubMed ID: 18217899
    [Abstract] [Full Text] [Related]

  • 12. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK, Bhowmik D, Mahajan S, Bagchi S.
    Transpl Infect Dis; 2017 Feb 01; 19(1):. PubMed ID: 27775825
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep 01; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 15. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr 01; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D, Keitel E, Heineck I, Cardoso BD, Rodrigues AP, Michel K, Garcia VD.
    Transplant Proc; 2010 Mar 01; 42(2):475-8. PubMed ID: 20304169
    [Abstract] [Full Text] [Related]

  • 18. Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
    Bunnapradist S, Takemoto SK.
    Transplant Proc; 2003 Nov 01; 35(7):2407-8. PubMed ID: 14611971
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
    Zhang X, Ji L, Yang L, Tang X, Qin W.
    Int Urol Nephrol; 2016 May 01; 48(5):731-43. PubMed ID: 26781720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.